Insider Trading & Ownership - Vivo Capital VIII LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vivo Capital VIII LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-04-01
Sale
2024-04-03
8:47 pm
Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
420,663$6.6487$2,796,859268,573
(Indirect)
View
2023-12-15
Sale
2023-12-19
6:00 pm
IMPEL PHARMACEUTICALS INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
575,000$0.12892$74,131280,294
(Indirect)
View
2023-11-21
Sale
2023-11-22
6:51 pm
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Panda LLC
Vivo Panda Fund L.P.
10% Owner
3,400$0.9$3,0601,559,948
(Indirect)
View
2023-11-16
Sale
2023-11-20
9:09 pm
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Panda LLC
Vivo Panda Fund L.P.
10% Owner
77,843$0.92875$72,2971,561,405
(Indirect)
View
2022-12-23
Purchase
2022-12-23
5:48 pm
Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
758,620$7.25$5,499,9956,657,992
(Indirect)
View
2022-09-07
Purchase
2022-09-08
8:00 pm
Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
600,000$3.6$2,160,0005,899,372
(Indirect)
View
2022-08-12
Purchase
2022-08-16
8:44 pm
Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
2,624,239$2.6599$6,980,2446,799,372
(Indirect)
View
2021-04-27
Purchase
2021-04-29
9:10 pm
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
575,000$15$8,625,000349,674
(Indirect)
View
2021-02-09
Purchase
2021-02-09
3:37 pm
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
350,000$20$7,000,000150,000
(Indirect)
View
2021-02-09
Sale
2021-02-09
3:37 pm
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
226$20$4,520150,000
(Indirect)
View
2021-02-09
Purchase
2021-02-09
3:08 pm
Terns Pharmaceuticals Inc.TERNVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
475,000$17$8,075,000357,353
(Indirect)
View
2020-10-20
Purchase
2020-10-20
4:59 pm
Aligos Therapeutics Inc.ALGSVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
550,000$15$8,250,000430,372
(Indirect)
View
2020-04-15
Sale
2020-04-17
6:38 pm
Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
330,598$15.45$5,106,752298,625
(Indirect)
View
2020-04-03
Sale
2020-04-07
7:27 pm
Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
306,115$13.81$4,226,833338,738
(Indirect)
View
2020-03-09
Sale
2020-03-11
5:12 pm
Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
528$19.5$10,296168,165
(Indirect)
View
2020-02-07
Sale
2020-02-11
8:00 pm
Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
13,460$21.66$291,587168,298
(Indirect)
View
2020-02-04
Sale
2020-02-06
7:22 pm
Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
13,460$22.8$306,888178,816
(Indirect)
View
2020-01-29
Sale
2020-01-31
8:00 pm
Crinetics Pharmaceuticals Inc.CRNXVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
26,920$22.07$594,164189,335
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
39,725,922$0349,674
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
101,456$13.5349,674
(Indirect)
View
2021-04-22
Other
2021-04-26
6:24 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,359,799$01,359,799
(Indirect)
View

Ownership
2021-04-22
9:30 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
0$02,208,333
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:37 pm
N/A
N/A
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
3,414,343$0150,000
(Indirect)
View
2021-02-09
Exercise
2021-02-09
3:37 pm
N/A
2028-07-26
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
64,319$0150,000
(Indirect)
View
2021-02-09
Exercise
2021-02-09
3:37 pm
N/A
N/A
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
Vivo Opportunity Fund L.P.
Vivo Opportunity LLC
10% Owner
64,319$0.07150,000
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:08 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
3,426,240$0357,353
(Indirect)
View

Ownership
2021-02-04
7:33 pm
N/A
N/A
Bolt Biotherapeutics Inc.BOLTVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Panda Fund L.P.
Vivo Panda LLC
10% Owner
0$03,521,517
(Indirect)
View

Ownership
2021-02-04
5:05 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
0$02,200,133
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
2,997,030$0430,372
(Indirect)
View

Ownership
2020-10-15
5:17 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
0$02,997,030
(Indirect)
View